Mesoderm Posterior 2 Homolog (Mesp2) Peptide
Mesp2
Reactivité: Humain, Souris
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits Mesp2
- Mesp2 (Mesoderm Posterior 2 Homolog (Mesp2))
- Origine
- Humain, Souris
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-MESP2 antibody (Catalog #: ARP36921_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- Mesp2 (Mesoderm Posterior 2 Homolog (Mesp2))
- Synonymes
- bHLHc6 Peptide, SCDO2 Peptide, mesoderm posterior 2 Peptide, mesoderm posterior bHLH transcription factor 2 Peptide, Mesp2 Peptide, MESP2 Peptide
- Sujet
-
Somite boundaries formed during embryogenesis, at the interface between Notch1-activated and -repressed domains. Genetic and biochemical studies indicate that this interface is generated by suppression of Notch activity by mesoderm posterior 2 (Mesp2) through induction of the lunatic fringe gene (Lfng). It is proposed that the oscillation of Notch activity is arrested and translated in the wavefront by Mesp2.
Alias Symbols: bHLHc6
Protein Interaction Partner: Lfng
Protein Size: 370 - Poids moléculaire
- 41 kDa
- ID gène
- 17293
- NCBI Accession
- NM_008589, NP_032615
- UniProt
- O08574
-
Vous êtes ici:
